The Role of Multiple Intensification in Medical Oncology 1st Editon 2013 Softbound at Meripustak

The Role of Multiple Intensification in Medical Oncology 1st Editon 2013 Softbound

Books from same Author: M.S. Aapro, Dominique Maraninchi

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 9832/- [ 5.00% off ]

    Seller Price: ₹ 9340

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)M.S. Aapro, Dominique Maraninchi
    PublisherSpringer
    Edition1st Edition
    ISBN9783662011584
    Pages54
    BindingSoftbound
    LanguageEnglish
    Publish YearMay 2013

    Description

    Springer The Role of Multiple Intensification in Medical Oncology 1st Editon 2013 Softbound by M.S. Aapro, Dominique Maraninchi

    Recent debate about the value of high-dose chemotherapy has centered on single therapy approaches. This concise, authoritative book discusses the possible utility of two or more consecutive high-dose therapies. Also discussed are novel ways to circumvent drug resistance, pharmacology, techniques of cell collection, and pharmacoeconomics. High Dose, Low Dose, No Dose: The Rights and Wrongs of Medical Oncology.- Haematological Support: Progenitor Cell Collection and Processing.- Pharmacotoxicology of High-Dose Thiotepa.- Pharmacotoxicology of High-Dose VP-16.- Intensive Sequential Chemotherapy for Untreated Poor-Risk Non-Hodgkin’s Lymphoma.- High-Dose Chemotherapy with Autologous Haematopoietic Progenitor Cell Transplantation for Adenocarcinoma of the Breast.- Multiple Alkylating Agent Chemotherapy for Solid Cancers.- The Health Economics of High-Dose Chemotherapy.